Sri Murali Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 77.17%
(FY 2017)
- Profit 113.86%
(FY 2017)
- Ebitda -4.57%
(FY 2017)
- Net Worth 12.72%
(FY 2017)
- Total Assets -45.93%
(FY 2017)
About Sri Murali Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Indumathy and Jayaraman Balaraman serve as directors at the Company.
- CIN/LLPIN
U52300TN2013PTC093329
- Company No.
093329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Murali Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indumathy  | Director | 14-Oct-2013 | Current |
| Jayaraman Balaraman | Director | 14-Oct-2013 | Current |
Financial Performance of Sri Murali Pharmaceuticals.
Sri Murali Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 77.17% increase. The company also saw a substantial improvement in profitability, with a 113.86% increase in profit. The company's net worth Soared by an impressive increase of 12.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Murali Pharmaceuticals?
In 2017, Sri Murali Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suresh Pharma Agencies (Chennai) Private LimitedActive 15 years 8 monthsIndumathy and Jayaraman Balaraman are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Murali Pharmaceuticals?
Unlock and access historical data on people associated with Sri Murali Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Murali Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Murali Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
